Huntington's disease (HD) is caused by expansion of a polyglutamine (polyQ) repeat in the huntingtin protein. A structural basis for the apparent transition between normal and disease-causing expanded polyQ repeats of huntingtin is unknown. The 'linear lattice' model proposed random-coil structures for both normal and expanded polyQ in the preaggregation state. Consistent with this model, the affinity and stoichiometry of the anti-polyQ antibody MW1 increased with the number of glutamines. An opposing 'structural toxic threshold' model proposed a conformational change above the pathogenic polyQ threshold resulting in a specific toxic conformation for expanded polyQ. Support for this model was provided by the anti-polyQ antibody 3B5H10, which was reported to specifically recognize a distinct pathologic A C C E P T E D M A N U S C R I P T
INTRODUCTION

Huntington's disease (HD) is a fatal neurodegenerative disorder characterized clinically A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
3 by psychiatric symptoms, cognitive decline, and uncontrolled movements [1] . HD is caused by expansion of a CAG repeat within exon 1 of HTT (previously HD) that encodes an expanded polyglutamine (polyQ) tract in the N-terminal portion of the huntingtin protein. A pathologic threshold exists for HD, in which HD is fully penetrant in patients with 42 or more glutamines in the huntingtin protein, but no disease is found in individuals with 36 or fewer glutamines, while huntingtin with 37 to 41 glutamines exhibits reduced HD penetrance [2] . Although a structural basis for an apparent normal-disease threshold is unknown, several hypotheses exist for the conformation of monomeric, soluble polyQ in normal and expanded huntingtin protein.
The 'linear lattice' hypothesis proposed that polyQ retains a random-coil structure for both normal and expanded polyQ in the preaggregation state. In this model, the increase in number of binding epitopes in expanded polyQ compared with normal polyQ results in avidity effects that cause higher apparent affinities for bivalent proteins such as antibodies [3] . This could induce altered binding interactions with other cellular proteins or other polyQ repeats, leading to neuronal toxicity. Consistent with this model, the affinity of the anti-polyQ antibody MW1 to huntingtin amino terminal protein encoded by exon 1 (hereafter called huntingtin exon 1 protein) increased in a polyQ-length dependent manner, and binding of multiple antigen-binding fragments (Fabs) of MW1 to expanded polyQ tracts was observed. In addition, huntingtin exon 1 protein with 16 -46 glutamines exhibited a random coil conformation in solution, and no evidence was found for a global conformation change above 37 glutamines [3, 4] . Surface plasmon resonance (SPR) and analytical ultracentrifugation (AUC) studies also demonstrated that multiple MW1 Fabs bound to expanded polyQ tracts [3] . The X-ray crystal structure of a GQ 10 G peptide bound to the variable regions of MW1 revealed that a short polyQ tract adopted an extended structure in a diagonal binding groove across the antigen-binding site of MW1 [4] .
Additional binding studies using the anti-polyQ antibody 1C2 [5] showed that 1C2 also exhibited preferential binding to expanded polyQ due to avidity effects, and this preferential binding was not due to a mutant huntingtin-specific toxic structure recognized by 1C2 [6] .
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In contrast, the 'structural toxic threshold' model proposed that a conformational transition occurs in polyQ repeats that are longer than the pathological threshold, which results in a specific toxic conformation for monomeric expanded polyQ that could potentially be recognized by antibodies [7] . According to this model, the postulated pathologic conformation could be directly toxic or it could alter interactions between mutant huntingtin and its binding partners; in either case, the pathologic conformation could be targeted for drug design. Support for this model was provided by studies of the anti-polyQ antibody 3B5H10, which was reported to recognize a single epitope representing a distinct pathologic conformation of soluble expanded polyQ [8, 9] . In these studies, 3B5H10 IgG preferentially bound to expanded polyQ, and a two-stranded β-hairpin conformation of polyQ was modeled into the predicted polyQbinding groove of the 3B5H10 Fab structure [9] . Support for this model was provided by a gel filtration assay of 3B5H10 Fab binding to a Q 39 -containing huntingtin exon 1 fusion (HD-39Q)
protein, which was interpreted to demonstrate a binding stoichiometry of 1:1 3B5H10 Fab:HD-39Q [8] . These results were suggested to indicate that 3B5H10 binds to a single structured polyQ epitope only present in expanded polyQ, as per the structural toxic threshold hypothesis.
Modeling of small-angle X-ray scattering (SAXS) data was interpreted as showing that 3B5H10
Fab bound to HD-39Q in a 2:2 3B5H10 Fab:HD-39Q complex in which each 3B5H10 Fab recognized one subunit of an HD-39Q dimer through binding to a two-stranded β-hairpin conformation of polyQ [9] . Contradictory evidence was provided by a recent report demonstrating that pull-down assays and surface plasmon resonance (SPR) studies showed that 3B5H10 IgG, like MW1 and 1C2 IgGs, could bind to short polyQ tracts, as expected given the high sequence and structural similarities between the three antibodies [6] .
Here we compared the recognition properties of the anti-polyQ monoclonal antibodies MW1 and 3B5H10 by studying their interactions with a polyQ-containing fragment of huntingtin.
Using expressed and purified huntingtin exon 1-thioredoxin (TRX) fusion proteins containing 16
A C C E P T E D M A N U S C R I P T 5   to 46 glutamines (HD-16Q, HD-25Q, HD-39Q, HD-46Q) (Fig. 1a) , we directly compared the interactions between soluble huntingtin and these anti-polyQ antibodies using biochemical and biophysical analysis techniques. We found that both MW1 and 3B5H10 antibodies exhibited similar binding properties, with neither providing evidence for a toxic conformation of expanded polyQ. These results argue against strategies designed to target a novel toxic conformation of soluble mutant huntingtin exon 1 protein in the preaggregation state.
ACCEPTED MANUSCRIPT
RESULTS
Both MW1 and 3B5H10 antibodies bind to normal and expanded polyQ within huntingtin exon 1 proteins
Western blots were used to evaluate the binding of 3B5H10 and MW1 IgGs to equimolar amounts of huntingtin exon 1-TRX fusion proteins and to the TRX tag alone (Fig. 1b) . If 3B5H10 recognizes a toxic conformation present only in expanded polyQ, then unlike MW1, it should not bind to short polyQ repeats. In contrast with some previous results [9] , but consistent with other results [10, 11] , we found that both MW1 and 3B5H10 IgGs bound in a similar manner to huntingtin exon 1 fusion proteins, each capable of binding to huntingtin exon 1 proteins containing both normal and expanded polyQ repeats. Both IgGs bound to huntingtin exon 1 proteins in a polyQ-dependent manner, with a progressively more intense signal with increased polyQ length. Based on these results, and previous western blots demonstrating the ability of 3B5H10 to bind to GST-polyQ with both short and long polyQ repeats [6] , we conclude that both antibodies recognize a similar polyQ epitope that is present in both normal and expanded huntingtin exon 1 proteins.
In order to determine how it is possible to obtain results appearing to indicate that 3B5H10 binds only to expanded polyQ, we examined binding of 3B5H10 and MW1 as a function of concentration to huntingtin exon 1 proteins with different polyQ repeat lengths. Dot blots of serial dilutions of huntingtin exon 1 proteins demonstrated that both 3B5H10 and MW1 IgGs A C C E P T E D M A N U S C R I P T
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6 bound to huntingtin exon 1 proteins in a length-and concentration-dependent manner (Fig. 1c) . [3, 12] .
Huntingtin exon 1 proteins are monomeric in solution
During purification of huntingtin exon 1 fusion proteins, we observed anomalous migration by gel filtration chromatography such that huntingtin exon 1 fusion proteins appeared to migrate as higher molecular weight proteins (e.g., dimers) when compared with molecular weight standards of globular proteins. To determine the oligomeric state of the huntingtin exon 1 fusion proteins, we used a combination of size-exclusion chromatography (SEC) with in-line multiangle light scattering (SEC-MALS), a technique that can be used to determine the absolute molecular mass of a protein or complex independent of shape and model [13] . To evaluate the methodology, we first analyzed 3B5H10 Fab alone, which migrated as a single monodisperse peak whose derived molecular mass closely matched the mass calculated from the amino acid sequence ( Fig. 2 ; Table 1 ). HD-16Q and HD-39Q fusion proteins also migrated as monodisperse peaks, and their calculated molecular masses corresponded to monomers in each case (Table 1) . Thus the anomalous migration of each huntingtin exon 1 protein in
positions expected for a dimeric version of a globular protein of the same molecular mass results from slower migration due to an elongated structure rather than from dimerization. In particular, no evidence was found for dimer formation for HD-39Q as predicted in a previous study involving the modeling of small-angle X-ray scattering (SAXS) data [9] .
Non-equilibrium gel filtration chromatography analyses yield inconsistent apparent binding stoichiometries
We next replicated published non-equilibrium gel filtration chromatography experiments that were conducted to determine the stoichiometry of binding between 3B5H10 Fab and huntingtin exon 1 protein with an expanded polyQ repeat using the same proteins: 3B5H10 Fab and HD-39Q [8] . By varying the ratio of 3B5H10 Fab to HD-39Q, we determined the ratio where the least amount of excess Fab or excess HD-39Q was detected, the method previously used to report a 1:1 3B5H10:HD-39Q binding stoichiometry [8] . Similar to the published results, we found that unbound 3B5H10 Fab was present at ratios greater than 1:1 3B5H10 Fab:HD-39Q, unbound HD-39Q was present at ratios less than 1:1, and that the ratio where the least amount excess of Fab or excess HD-39Q could be detected was 1:1 ( Fig. 3a) . As a control, we repeated the non-equilibrium gel filtration stoichiometry experiment to evaluate the binding behavior of MW1 Fab and HD-39Q ( Fig. 3b) , which was previously shown to form a complex with a greater than 1:1 stoichiometry [3] . Under non-equilibrium conditions, the stoichiometry of MW1 Fab:HD-39Q appeared to be less than 1:1. Thus it appeared that non-equilibrium gel filtration could not be reliably used to derive an accurate binding stoichiometry for an anti-polyQ Fab binding to huntingtin exon 1 fusion proteins with expanded polyQ.
However, we noted that with increasing molar ratios of 3B5H10 Fab:HD-39Q, the complex peak eluted earlier on the gel filtration column, suggesting that a complex larger than 1:1 was forming at the same time as 3B5H10 Fab was dissociating from HD-39Q. Due to the anomalous migration of HD-39Q compared with globular proteins using gel filtration
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8 chromatography (see above), the molecular mass of the 3B5H10 Fab:HD-39Q complex peak could not accurately be estimated based on gel filtration migration. Using SEC-MALS, we found that the complex of 3B5H10 Fab and HD-39Q was polydisperse, and the molecular mass of the peak fraction corresponded to a complex composed of greater than a 1:1, but less than a 2:1, ratio of 3B5H10 Fab:HD-39Q ( Table 1 ), demonstrating that dissociation of the complex occurred during the experiment. In contrast, the complex of 3B5H10 Fab and HD-16Q migrated as a monodisperse peak, and the calculated molecular mass for a 1:1 3B5H10 Fab:HD-16Q stoichiometric ratio was in close agreement with the molecular mass obtained by SEC-MALS (Table 1) .
Taken together, the results for these experiments suggested that binding stoichiometries for MW1 and 3B5H10 Fabs binding to huntingtin exon 1 proteins as determined by nonequilibrium gel filtration are incorrect. This is likely because protein complexes that dissociate during this procedure are unable to rebind due to separation by the gel filtration column.
Therefore depending on the binding kinetics and the amount of separation between anti-polyQ Fabs and huntingtin exon 1 proteins on the gel filtration column, the binding stoichiometries determined by non-equilibrium gel filtration techniques may be artificially low, as has been found in other protein-protein interaction systems evaluated by this technique [14, 15] .
Expanded polyQ tracts within huntingtin exon 1 proteins contain multiple epitopes for the antigen-binding fragments (Fabs) of MW1 and 3B5H10
To determine an accurate stoichiometry of binding between HD-39Q and the Fabs of 3B5H10 and MW1, we used equilibrium gel filtration [16] . In this technique, a chromatography column is run with an equilibration buffer containing one of the binding partners (e.g., protein A).
Different ratios of the binding partners (e.g., protein A and protein B) are then injected onto the column. When the amount of additional protein A injected is less than that required for formation of a complex, a trough will form at the position that protein A migrates. If the amount of
additional protein A injected is in excess for complex formation, a peak is observed at the position that protein A migrates. When the amount of additional protein A injected is at the amount required for complex formation, a flat baseline is observed at the position that protein A migrates. However, unless the protein concentration in the equilibration buffer is much greater than the affinity of the protein-protein complex, the ratio of protein A to protein B at which a flat baseline is observed will not be an integer, in which case the correct stoichiometry can be obtained by rounding up to the next integer [14] or by Scatchard analysis [15] . Previous measurements demonstrated a higher polyQ binding affinity for 3B5H10 Fab than for MW1 Fab: complexes varied from 1-7 mg/mL, higher than the concentrations used for equilibrium gel filtration experiments. As expected, the R h values derived for the 3B5H10 and MW1 Fabs, which are globular proteins of similar dimensions, were roughly the same, and both R h values were smaller than the R h values for HD-16Q and HD-39Q (Table 2) , consistent with the proposed elongated structures of HD-16Q and HD-39Q [3] (Table 2) . Notably, the R h value for HD-16Q
was smaller than for HD-39Q, inconsistent with the compact structure proposed for expanded polyQ [9] . When complexed with huntingtin exon 1 proteins, both Fabs exhibited qualitatively similar behavior: the R h values were lower for the Fab complexes with HD-16Q than with HD-39Q. Based on our gel filtration and SEC-MALS data ( 39Q complexes showed ideal sample quality characteristics (Fig. S2 ). Guinier analysis [17] indicated minimal aggregation for both Fabs alone and Fabs complexed with HD-16Q and HD-39Q and for all huntingtin exon 1 fusion proteins alone (Fig. S3) . Radii of gyration (R g ) determined by SAXS were consistent with R h values determined by DLS (Table 2 ). In particular, for measurements of huntingtin exon 1 fusion proteins alone, we did not see substantially increased R h or R g values for HD-39Q compared with HD-16Q, consistent with computational modeling of polyQ in aqueous solution suggesting that radii of polyQ tracts of increasing lengths are similar [18] , but inconsistent with the structural toxic threshold model predicting a conformational transition for expanded polyQ tracts [9] . The predicted molecular weights of the complexes of 3B5H10 or MW1 Fab bound to HD-16Q in a 1:1 complex were similar to the molecular weights calculated based on the extrapolated scattering intensity at zero angle [19] .
However, 3B5H10 Fab or MW1 Fab bound to HD-39Q formed complexes with observed molecular weights larger than a 1:1 complex. Based on molecular weight alone, these complexes could be 2:1, 3:1, or 2:2 Fab:HD-39Q complexes. A 2:2 3B5H10 Fab:HD-39Q stoichiometry was postulated to account for previous SAXS data [9] . However, our SEC-MALS
and equilibrium gel filtration data demonstrated that 3B5H10 Fab does not bind to HD-39Q in a 2:2 ratio (Fig. 2) . Therefore, we interpret our SAXS data for both 3B5H10 and MW1 Fab binding to HD-39Q as evidence for mixtures of 2:1 and 3:1 Fab:HD-39Q complexes.
Kratky analysis was used to evaluate the relative degree of folding of each sample [20] .
The Kratky plots for MW1 and 3B5H10 Fabs alone yielded bell-shaped peaks consistent with globular proteins [21, 22] (Fig. 5a ). By contrast, the Kratky plots for HD-16Q and HD-39Q were broader, with less degrease at higher scattering angles, consistent with flexible or unfolded proteins [21, 22] (Fig. 5b) . Thus we found no evidence for a conformational change occurring for HD-39Q relative to HD-16Q. Similarly, we found no systematic differences for 3B5H10 versus MW1 Fab complexes with either HD-16Q or HD-39Q (Fig. 5c,d ). These results are consistent with both Fabs exhibiting similar recognition properties for polyQ tracts.
Three-dimensional structures can be modeled into SAXS profiles; however, modeling is limited by the one-dimensional nature of SAXS data, and more than one 3-D shape can produce the same one-dimensional scattering profile [23] . We did not attempt to fit atomistic models into the SAXS data as done in a previous study [9] because (i) the complete 3-D structure of huntingtin exon 1 protein is unknown, (ii) the polyQ tract within huntingtin exon 1 fusion proteins adopts flexible random coil structures in solution [3] , and (iii) the arrangements between polyQ tracts, the remainder of huntingtin exon 1, the TRX fusion partner, and the His purification tag cannot be predicted. Nor did we assume that the huntingtin exon 1 fusion proteins were dimeric, as also done for interpretation of SAXS data involving HD-39Q bound to 3B5H10 Fab [9] , because our SEC-MALS data demonstrated that HD-39Q is monomeric in solution (Fig. 2) .
Instead, we used minimal assumptions to generate ab initio models that predicted molecular envelopes from the SAXS data for each of the well-behaved samples. We did not find notable differences between 3B5H10:HD-39Q and MW1:HD-39Q complexes based on R g , D max , or shape or volume of calculated envelopes (Fig. 6 , Table 2 ), as would be predicted by the toxic conformation model suggesting that 3B5H10, but not MW1, recognizes a compact conformation of expanded polyQ [9] . Instead, in agreement with experiments described above and in previous reports [3, 4, 6, 12] , the SAXS results were consistent with recognition of multiple epitopes within a linear lattice of expanded polyQ by both Fabs.
DISCUSSION
The structure of huntingtin exon 1 protein in the preaggregation state, particularly the conformation of the expanded polyQ repeat, is hypothesized to be critical in understanding the pathogenesis of HD. However, the structure of the basic components of huntingtin exon 1 remains controversial. An X-ray crystal structure of a Q 17 huntingtin N-terminal region fused to MBP showed that a short polyQ region could adopt either α-helical, loop, or random coil conformations [24] . The structure of a Q 10 peptide bound to the anti-polyQ antibody MW1
revealed an extended structure [4] . Other recent work suggested that the polyQ repeat acts as a flexible hinge that exhibits reduced flexibility at extended polyQ lengths [25] . In the present study, we show that the binding properties of the anti-polyQ antibodies MW1 and 3B5H10 support the 'linear lattice' model for the structure of soluble polyQ in the context of a huntingtin Several lines of evidence, reported here and in previous publications [6, 11] , have shown that 3B5H10 and MW1 IgGs can bind to a normal polyQ repeat, demonstrating that neither antibody preferentially recognizes a novel structure formed by expanded polyQ, but instead both recognize a short stretch of polyQ. This conclusion is in contrast to other studies suggesting that 3B5H10 bound preferentially to expanded polyQ repeats of mutant huntingtin according to a 'structural toxic threshold' model, in which a conformational transition occurs in the polyQ repeat of huntingtin exon 1 protein at the pathologic threshold (>37Q) [9] . Instead our results agree with the conclusions of a recent study comparing the binding of anti-polyQ antibodies 1C2 and 3B5H10 to polyQ repeats [6] .
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To evaluate whether an expanded polyQ tract contains one epitope for anti- and MW1 (PDB code 2GSG) crystal structures (calculated for all Cα atoms). In addition, the antigen-binding sites of both antibodies include an unusual diagonal groove [6] shown to accommodate a single extended stretch of polyQ in an MW1-polyQ co-crystal structure [4] , and thus unlikely to bind to a two-stranded β-hairpin structure of polyQ, as modeled for the HD-39Q
interaction with 3B5H10 Fab [9] .
Reduced penetrance is seen in patients with between 37 and 41 glutamine repeats in the huntingtin protein, which may be best explained by a quantitative change in a rate-limiting process in which the effects can be countered in some patients and not in others due to environmental or genetic modifiers. This reduced penetrance is consistent with a continuous linear lattice effect that is weak at lower polyQ repeat lengths and progressively stronger at larger repeat lengths. These results are relevant to potential therapeutic approaches to target soluble expanded polyQ in a lag period preceding aggregation. As we find no evidence for recognition of a specific conformation of expanded polyQ within huntingtin exon 1 proteins in either this study or previous studies [3, 4, 6, 12] , we suggest that efforts to target expanded polyQ using monomeric binding partners are unlikely to be successful in discriminating polyQ stretches found in non-disease proteins such as transcription factors [26, 27] from expanded polyQ within mutant huntingtin exon 1. Instead, we suggest strategies in which reagents that recognize short stretches of polyQ are covalently linked to allow avidity effects to discriminate between short and expanded polyQ tracts.
MATERIALS AND METHODS
Protein expression and purification
Human huntingtin exon 1 encoded protein (comprising 91 amino acids when containing 16 glutamine residues) including different sized polyQ segments (Q16, Q25, Q39, and Q46) coded for by CAG or CAA/CAG repeats was expressed as a fusion protein with thioredoxin (TRX). Exon 1 fusion proteins were purified as previously described [3] with the following modifications: autoinduction was used to culture cells to high densities [28] , and sonication was used for cell lysis. Purified proteins were flash frozen and stored at -80°C in 50 mM Tris (pH 8.0) and 150 mM NaCl. 
SEC-MALS
Purified proteins or protein complexes were characterized by SEC-MALS to determine absolute molecular masses [13] . Proteins were concentrated to 1 mg/mL, passed through a 0. and then injected onto the column. Chromatography was performed at a flow rate of 50 µL/min using a SMART micropurification system (Pharmacia), and the absorbance of the eluent was monitored at 280 nm.
Dynamic light scattering (DLS)
DLS measurements were conducted on a DynaPro® NanoStar TM (Wyatt Technology, Goleta, CA) at 25°C. All samples were purified using a Superdex 200 10/300 column in 50 mM
Tris (pH 8.0), 150 mM NaCl prior to DLS and SAXS measurements, and the same sample preparations were used for both experiments. Fractions were pooled and concentrated to at least 2 mg/mL and filtered through 0.2 µm membranes (Millipore). Samples were equilibrated to 25°C prior to DLS measurements. Data were analyzed using Dynamics V7.1.2 software (Wyatt Technology) to calculate hydrodynamic radii (R h ).
Small angle X-ray scattering (SAXS)
Small angle X-ray scattering experiments were conducted at beamline 4-2 at SSRL using a Rayonix MX225-HE detector at a distance of 2500 mm, using 1.13 Å wavelength Xrays. Protein preparations for DLS measurements were used for SAXS data collection. For each protein or complex, scattering intensity was measured at four protein concentrations (0.5-7 mg/mL), collecting 10 exposures of 1 second each, covering a momentum transfer (q) range of 0.0047-0.375 1/Å. The scattering profile for the buffer was obtained in the same manner.
Scattering curves collected from protein samples were corrected for background scattering using the intensity data collected from the buffer alone using SasTool [31] .
SAXS scattering curves were scaled, high and low q regions of scattering curves were merged to extrapolate to infinite dilution, and Guinier analysis was performed using PRIMUS [32] . R g values were calculated from Guinier plots. Scattering curves were overlaid to check for concentration-dependent effects on the scattering profile. GNOM [17] was used to calculate pairwise distribution functions. Porod volumes were calculated from DATPOROD [33] . Fab:huntingtin complexes, we listed a lower limit (100% 1:1) and upper limit (100% 3:1) for potential complex sizes.
For each protein or complex, at least 10 ab initio models were generated using DAMMIF [34] . Models were superimposed and averaged using DAMMIN [35] and DAMAVER [36] in the ATSAS package [33] , and resulting models were filled with dummy atoms. 
Author contributions
